http://www.prweb.com/releases/2011/9/prweb8838237.htm
Aderans Research Draws National Attention
Aderans Research experts shared their findings across the country this month, from Atlanta to Alaska. Distinguished representatives from the hair regeneration institute were invited to present at two prestigious conferences: the International Society of Hair Restoration Surgery (ISHRS) 19th Annual Scientific Meeting and the Georgia Life Sciences Summit 2011.
ShareThis Email PDF Print Atlanta, GA (PRWEB) September 29, 2011
The ISHRS meeting, titled “New Vistas & Trusted Techniques in Hair Transplantation,†was held September 14-18 in Anchorage, Alaska. Aderans Chief Executive Officer Ken Washenik, M.D., Ph.D., attended, leading a presentation on cell and gene therapy and moderating a session about advances in scarring types of hair loss and the role of hair transplantation in non-androgenetic alopecia. He also directed a workshop entitled “Understanding Cell Therapy and Related Follicular Research Advances,†focusing on the use of regenerative molecular and cell therapy in the manipulation of hair follicles to increase growth.
“We’re getting closer and closer to solving the puzzle of cellular hair regeneration and are pleased to be able to share our findings and thoughts with prominent members of the scientific and medical communities,†Washenik said. “These conferences are important for us because they bring together hair restoration surgeons, clinicians and scientific researchers to exchange insights and expand our collective knowledge of the follicular regeneration and restoration processes.â€
On September 27th in Atlanta, Aderans Principal Scientist Bryan Marshall, Ph.D., presented at the Georgia Life Sciences Summit 2011 “Bioscience at a Crossroads.†Marshall presented an Aderans poster entitled “Fibroblasts Derived from Human Scalp are Multipotent and Trichogenic†in the Cell Therapy & Tissue Engineering session and discussed the isolation of fibroblasts in the human adult scalp and their role in follicle production.
“The detection of multipotent cells in this manner in the human scalp is a big step toward using cellular regeneration to address pattern hair loss,†said Kurt Stenn, MD, Vice President and Chief Scientific Officer. “We’re excited to explore ways to translate this finding into clinical applications.â€
For more information about Aderans Research, visit http://www.aderansresearch.com.
About Aderans Research
Aderans Research is a pioneer in the research and development of safe, effective cell engineered products for hair regeneration. Located in Atlanta, Aderans Research is a subsidiary of Aderans Co., Ltd, the world’s largest wig manufacturer, and affiliate of Bosley, a global leader in surgical hair restoration.
Ongoing information on ARI’s clinical study can be seen at http://aderansresearch.com/ari_clinicalupdates.html.
Additional information on ARI can be found at http://www.aderansresearch.com.
Learn more about ARI’s parent company Aderans Co., Ltd. at http://www.aderans.com/english/index.html.
Aderans Research Draws National Attention
Aderans Research experts shared their findings across the country this month, from Atlanta to Alaska. Distinguished representatives from the hair regeneration institute were invited to present at two prestigious conferences: the International Society of Hair Restoration Surgery (ISHRS) 19th Annual Scientific Meeting and the Georgia Life Sciences Summit 2011.
ShareThis Email PDF Print Atlanta, GA (PRWEB) September 29, 2011
The ISHRS meeting, titled “New Vistas & Trusted Techniques in Hair Transplantation,†was held September 14-18 in Anchorage, Alaska. Aderans Chief Executive Officer Ken Washenik, M.D., Ph.D., attended, leading a presentation on cell and gene therapy and moderating a session about advances in scarring types of hair loss and the role of hair transplantation in non-androgenetic alopecia. He also directed a workshop entitled “Understanding Cell Therapy and Related Follicular Research Advances,†focusing on the use of regenerative molecular and cell therapy in the manipulation of hair follicles to increase growth.
“We’re getting closer and closer to solving the puzzle of cellular hair regeneration and are pleased to be able to share our findings and thoughts with prominent members of the scientific and medical communities,†Washenik said. “These conferences are important for us because they bring together hair restoration surgeons, clinicians and scientific researchers to exchange insights and expand our collective knowledge of the follicular regeneration and restoration processes.â€
On September 27th in Atlanta, Aderans Principal Scientist Bryan Marshall, Ph.D., presented at the Georgia Life Sciences Summit 2011 “Bioscience at a Crossroads.†Marshall presented an Aderans poster entitled “Fibroblasts Derived from Human Scalp are Multipotent and Trichogenic†in the Cell Therapy & Tissue Engineering session and discussed the isolation of fibroblasts in the human adult scalp and their role in follicle production.
“The detection of multipotent cells in this manner in the human scalp is a big step toward using cellular regeneration to address pattern hair loss,†said Kurt Stenn, MD, Vice President and Chief Scientific Officer. “We’re excited to explore ways to translate this finding into clinical applications.â€
For more information about Aderans Research, visit http://www.aderansresearch.com.
About Aderans Research
Aderans Research is a pioneer in the research and development of safe, effective cell engineered products for hair regeneration. Located in Atlanta, Aderans Research is a subsidiary of Aderans Co., Ltd, the world’s largest wig manufacturer, and affiliate of Bosley, a global leader in surgical hair restoration.
Ongoing information on ARI’s clinical study can be seen at http://aderansresearch.com/ari_clinicalupdates.html.
Additional information on ARI can be found at http://www.aderansresearch.com.
Learn more about ARI’s parent company Aderans Co., Ltd. at http://www.aderans.com/english/index.html.
